Form 4: Ligand Pharmaceuticals Executive Acquires Shares Through Employee Stock Purchase Plan

Andrew Reardon, Chief Legal Officer of Ligand Pharmaceuticals, acquired 329 shares of common stock through the company's Employee Stock Purchase Plan on June 28, 2024.

Summary

• On June 28, 2024, Andrew Reardon, the Chief Legal Officer of Ligand Pharmaceuticals, acquired 329 shares of common stock.
• The acquisition was made through the Ligand Employee Stock Purchase Plan.
• The price per share was $60.707.
• Following the transaction, Reardon directly owns 22,534 shares of Ligand Pharmaceuticals.
• The transaction was reported on July 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (executive stock purchase) which is generally seen as a good sign, but it's not a major event that would significantly impact sentiment.

Positives

• The acquisition of shares by a company executive through the Employee Stock Purchase Plan can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Executive stock purchases are common and are often viewed as a positive signal, reflecting the executive's belief in the company's prospects. These transactions are closely monitored by investors for insights into management's sentiment.

Comparison to Industry Standards

• Executive stock purchases are a common practice across the pharmaceutical industry.
• Similar transactions can be observed at companies like Pfizer (PFE), Merck (MRK), and AbbVie (ABBV), where executives periodically acquire shares of their own company's stock.
• The scale of the purchase (329 shares) is relatively small, suggesting it's more of a routine participation in the employee stock purchase plan rather than a major strategic investment.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company executive.
• Employees participating in the stock purchase plan benefit from the opportunity to acquire company stock.

Key Dates